Beth Hecht - 23 Jun 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Reporting relationship: Director
Issuer ticker: ITRM
Reported as of: 23 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2021, 16:05:21 UTC
Next SEC filing: 05 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Beth P. Hecht

Key filing fact

Beth Hecht filed Form 4 for Iterum Therapeutics plc (ITRM) on 25 Jun 2021.

Key facts

This page summarizes Beth Hecht's Form 4 filing for Iterum Therapeutics plc (ITRM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2021, 16:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ITRM transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +36,798
Change %
Price: $0.000000
Shares after: 36,798
Date: 23 Jun 2021
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 36,798
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.

Footnote F2

Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 23, 2022.